Nikoleta Dobromirova Ivanova

Mrs. Nikoleta Dobromirova Ivanova


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NINikoleta Dobromirova Ivanova
Nikoleta Dobromirova Ivanova
SIStoyan Ivanov
Stoyan Ivanov
Stefan PeevStefan Peev
Stefan Peev
TDTsanka D. Dikova
Tsanka D. Dikova
Background: The growing demand for effective methods of bone tissue regeneration highlights the relevance of studying modern bone substitutes and their applications in regenerative medicine. The aim of this work was to conduct a comprehensive analysis of the biological, mechanical, and clinical characteristics of various types of bone substitutes to determine their potential in regenerative medicine. Methods: The study was performed as a systematic literature review in accordance with PRISMA guidelines, analyzing 68 high-quality scientific sources from 2019 to May 2025, using the PubMed, Scopus, Web of Science, and Google Scholar databases. Results: It was established that autogenous grafts exhibit the highest osteogenic properties due to the presence of growth factors BMP-2, BMP-7, and concentrated growth factors; however, their use is limited by donor site morbidity in 20–30% of patients and the requirement to treat 6% of fractures complicated by non-union. Allogeneic and xenogeneic substitutes provide structural support for large defects but require intensive processing in accordance with European Directives 2004/23/EC and 2006/86/EC to minimize the risk of infection transmission. Synthetic substitutes based on calcium phosphate ceramics with pore sizes ranging from 23 to 210 micrometres demonstrate excellent biocompatibility and controlled degradation, with β-tricalcium phosphate exhibiting optimal characteristics for long-term applications compared to calcium sulphate. Conclusions: The findings of the study highlight the necessity of a personalized approach in selecting bone substitutes, considering the specific requirements of medical specialities, and support the development of hybrid biomaterials to combine structural strength with biological activity.

23 June 2021 in Scripta Scientifica Pharmaceutica
Verified
Journal Article
Open access
PDF file
NINikoleta Dobromirova Ivanova
Nikoleta Dobromirova Ivanova
GYGalina Yaneva
Galina Yaneva
DIDobri Ivanov
Dobri Ivanov
Introduction In the last decade, platelet-rich concentrates, including the so-called platelet-rich plasma (PRP), have been gaining extreme popularity and are widely used in variety of clinical fields of medicine—dermatology, orthopedics, traumatology, plastic and reconstructive surgery, maxillofacial surgery, and others. Aim The aim of the article was to analyze the quantitative characteristics of the blood components in autologous platelet-rich plasma concentrates obtained by the buffy coat technique using different protocols. Materials and Methods Thirty participants (avg. age 42.8) were included in the present study. Venous blood (35 mL) was drawn from each participant—3 mL were separated for control group to determine average blood cell level. Four protocols for PRP obtaining (4 x 8 mL) were performed by using vacutainer tube with separating gel and monovette (S-Monovette) without a separating gel. The concentration factor (%) for each protocol was calculated relative to the average baseline blood values of the control group. Results Protocol I showed increase in platelet concentrations by 91.55% and the leukocyte level was 107% higher compared to the control group. The second protocol (separating gel) demonstrated increase in platelet count by 337.06% and in leukocytes by 82.37%. The third protocol, based on double centrifugation, showed 352.08% increase in platelets and 40.54% decrease in white blood cell compared to controls. The fourth protocol demonstrated 389.84% increase in platelet level and 74.36% decrease in leukocyte number. Conclusion The use of separating gels into various techniques for obtaining PRP facilitates blood cell aspiration and makes the procedure faster and safer in ambulatory practice.

25 September 2025 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
NINikoleta Dobromirova Ivanova
Nikoleta Dobromirova Ivanova
SIStoyan Ivanov
Stoyan Ivanov
TDTsanka D. Dikova
Tsanka D. Dikova
Purpose: The surface coatings of implants primarily used in orthopedics and dentistry are developed to improve osseointegration with the body's tissues and ensure durability and functionality. In surgical practice, there is large diversity of options for grafting materials to manage bone loss, promote osteoinduction and accelerate implant integration and survival. The aim of the present study is to analyze and evaluate the biomedical characteristics of Chitosan, Bioactive glass and Laponite®/BMP-2 as potential substances for surface coatings of implants. Material/Methods: A search for scientific studies was conducted in the electronic databases: Google Scholar and PubMed for a period of ten years (2014-2024)ith keywords: Biomedical characteristics, Chitosan, Bioactive glass, Laponite (BMP-2), implant surface coatings. Results: Results demonstrated that chitosan used as a coating for implant materials promotes osteointegration both in vitro and in vivo. Coating the implant with bioactive glasses leads to improved stability as well as the connection between the coating and the implant. The combination of Laponite®'s biocompatibility and the osteoinductive properties of BMP-2 as surface implant coating can enhance the healing of bone defects and accelerate osteointegration. Conclusion: This review highlights the main characteristics of commonly used bone substitutes and provides guidance on their clinical use in orthopedic and traumatology practice and periodontal treatment in terms of improving their durability.

5 October 2026 in Prague Medical Report
Verified
Journal Article
Open access
PDF file
NINikoleta Dobromirova Ivanova
Nikoleta Dobromirova Ivanova
The aim of the study was to determine optimal methods for preparing platelet-rich plasma to maximise the yield of key growth factors, which is essential for standardising clinical applications in regenerative medicine. The study, conducted on 30 healthy volunteers, compared four centrifugation protocols for their effect on protein composition: method 1 (single centrifugation without gel), method 2 (single centrifugation with gel), method 3 (double centrifugation without gel), and method 4 (double centrifugation with gel), followed by activation with calcium gluconate and quantitative analysis. It was found that double centrifugation with a separating gel provided consistently high concentrations of transforming growth factor-β1 (25.17–25.37 ng/ml) without activation, exceeding the values obtained from single centrifugation by 2.4 times. In contrast, single centrifugation with a gel followed by activation resulted in peak concentrations of platelet-derived growth factor-AB (10.59 ± 2.129 ng/ml), which was 44% higher than those achieved with double centrifugation. Statistical analysis confirmed significant differences between the methods (Student’s t -test, p10.5 fl) and increased yield of platelet-derived growth factor-AB by 22–25%. The findings demonstrate that the maximum bioavailability of TGF-β1 is achieved with double centrifugation using gel, whereas plasma rich in growth factors is obtained by single centrifugation with gel combined with activation. The proposed optimisation enables targeted plasma preparation: double centrifugation with gel without activation for bone regeneration, and single centrifugation with gel with activation for angiogenic procedures, reducing costs by 20% and improving regenerative efficacy.

30 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
IKIvayla Kuleva
Ivayla Kuleva
Stoyan Nikolov StoyanovStoyan Nikolov Stoyanov
Stoyan Nikolov Stoyanov
MTMaria Tsvetkova
Maria Tsvetkova
NINikoleta Dobromirova Ivanova
Nikoleta Dobromirova Ivanova
DCDzheni Cherneva
Dzheni Cherneva
Galina Aleksieva YanevaGalina Aleksieva Yaneva
Galina Aleksieva Yaneva
Background/Objectives: Triple-negative breast cancer (TNBC) is an aggressive and molecularly heterogeneous breast cancer subtype for which early detection remains clinically important. Circulating non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are being investigated as blood-based biomarkers. This narrative review evaluates the clinical evidence for circulating ncRNAs as liquid-biopsy biomarkers for early TNBC detection, focusing on stage I–II disease, diagnostic performance, comparator selection, and validation. Methods: Peer-reviewed studies published between 2009 and October 2026 were identified primarily through PubMed/MEDLINE searches, supplemented by Google Scholar searches, with particular attention to disease stage, comparator populations, diagnostic performance, and validation status. Results: Among the ncRNA classes reviewed, circulating miRNAs provide the most directly relevant, although still limited, clinical evidence for early-stage TNBC detection, whereas evidence for lncRNAs and circRNAs remains predominantly exploratory and insufficiently validated for early-stage detection. Translation is limited by small, heterogeneous cohorts, analytical variability, and insufficient independent and prospective validation. Conclusions: High diagnostic accuracy in selected cohorts does not establish clinical readiness. Standardized analytical workflows, independent multicenter validation, prospective evaluation in intended-use populations, and integration with imaging and clinical assessment are needed before circulating ncRNA signatures can be considered for clinical use.

17 February 2026 in Materials Science
Verified
Journal Article
Open access
PDF file
NINikoleta Dobromirova Ivanova
Nikoleta Dobromirova Ivanova
SIStoyan Ivanov
Stoyan Ivanov
Galina Aleksieva YanevaGalina Aleksieva Yaneva
Galina Aleksieva Yaneva
Stefan PeevStefan Peev
Stefan Peev
TDTsanka D. Dikova
Tsanka D. Dikova
Osteosarcoma treatment requires a multidisciplinary team approach. Standard therapy for localized osteosarcoma includes a combination of chemotherapy and surgical intervention. Survivors require specialized long-term follow-up, as both chemotherapy and surgery may lead to significant and lasting adverse effects on patients’ quality of life. The aim of this article is to explore the potential of innovative osteosarcoma treatment strategies involving bioactive glass. To review the scope of existing studies on the applicability of mesoporous bioactive glass doped with inorganic compounds in osteosarcoma, scientific publications from global sources were analyzed. The literature search was conducted in February and March 2025 using the electronic databases PubMed, Google Scholar, and ResearchGate. A total of 42 full-text articles were identified, with a substantial increase in publications over the past five years, reflecting the growing scientific interest in this topic. Mesoporous bioactive glass represents a specialized class of bioactive materials with excellent capacity for controlled drug release in malignant tumors. This type of glass exhibits structural characteristics similar to mesoporous silicate materials while retaining the compositional features typical of conventional bioactive glasses. The combination of traditional therapy with the synergistic bone-regenerative potential of mesoporous bioactive glass provides a strong foundation for the development of new treatment approaches for bone cancer. Evidence indicates that ions released from mesoporous bioactive glasses demonstrate high therapeutic efficacy in cancer treatment and tissue engineering.